Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • Equities
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Macro Notification
  • Management
  • Market Summary
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Mining
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week
Browsing Category

Analyst Color

Analyst Color

Group By Ticker
Sort By
Newest | Oldest
Read More
2 minute read
  • Analyst Color
  • Analyst Ratings
  • Movers
  • News
  • Price Target
  • Reiteration
  • Tech
  • Trading Ideas

Bill.com Shares Gain As Analysts Cheer Its Q4 Performance

By Anusuya Lahiri
August 19, 12:17 PM
Bill.com Holdings, Inc (NYSE: BILL) clocked 156% revenue gr

BILL

Read More
2 minute read
  • Analyst Color
  • Analyst Ratings
  • News
  • Tech

Apple Could Look To Beat Recession Risk By Shipping iPhone 14 Earlier, Says Analyst

By Shivdeep Dhaliwal
August 19, 8:08 AM
Apple Inc (NASDAQ: AAPL) may ship its iPhone 14 models earlier than it had shipped the previous iterations, said analyst Ming-Chi Kuo.

AAPL

Read More
1 minute read
  • Analyst Color
  • Analyst Ratings
  • Initiation
  • News
  • Price Target

Wabtec’s Multi-Year Growth Algorithm Is ‘Underappreciated,’ Says This Analyst

By Akanksha Bakshi
August 18, 3:58 PM
Raymond James analyst Patrick Tyler Brown initiated coverage of Westinghouse Air Brake Technologies Corp (NYSE:WAB) (Wabtec) with an Outperform rating and a…

WAB

Read More
1 minute read
  • Analyst Color
  • Analyst Ratings
  • News
  • Price Target
  • Reiteration

Tapestry’s Outlook Offers ‘An Encouraging Sign,’ Says This Analyst

By Shivani Kumaresan
August 18, 3:52 PM
Telsey Advisory Group analyst Dana Telsey reiterated an Outperform rating on Tapestry Inc (NYSE:TPR) with a price target of $46.00. The analyst said…

TPR

Read More
1 minute read
  • Analyst Color
  • Analyst Ratings
  • General
  • News
  • Price Target
  • Reiteration

Estee Lauder’s Conservative Annual Guidance ‘Expected,’ Says This Analyst

By Shivani Kumaresan
August 18, 3:20 PM
Telsey Advisory Group analyst Dana Telsey reiterated an Outperform rating on Estee Lauder Companies Inc (NYSE:EL) with a price target of $377.00. The…

EL

Read More
1 minute read
  • Analyst Color
  • Analyst Ratings
  • Biotech
  • General
  • Health Care
  • News
  • Price Target
  • Small Cap

Caribou’s Blood Cancer Candidate Shows Response Rates Better Than Novartis,’ This Analyst Writes

By Vandana Singh
August 18, 2:14 PM
Last week, Caribou Biosciences Inc (NASDAQ:CRBU) announced Q2 earnings and provided updated results from the Phase 1 ANTLER trial of the company’s…

CRBU

Read More
1 minute read
  • Analyst Color
  • Analyst Ratings
  • Biotech
  • General
  • Health Care
  • News
  • Price Target

Blueprint Medicines’ Ayvakit ‘Will Garner Approval’ Despite Questions, This Analyst Says

By Vandana Singh
August 18, 2:08 PM
HC Wainwright has cut the price target on Blueprint Medicines Corporation (NASDAQ:BPMC) from $100 to $80 and reiterated the Buy rating. The analyst…

BPMC

Read More
1 minute read
  • Analyst Color
  • Analyst Ratings
  • Biotech
  • General
  • Health Care
  • Movers
  • News
  • Small Cap
  • Trading Ideas

Analysts Are Bullish On 89bio’s NASH Data Slated For Early Next Year

By Vandana Singh
August 18, 2:02 PM
Earlier today, 89bio Inc (NASDAQ:ETNB) concluded enrollment in ENLIVEN Phase 2b trial of pegozafermin for non-alcoholic steatohepatitis (NASH), enabling topline results in…

AKRO

Read More
1 minute read
  • Analyst Color
  • Analyst Ratings
  • Downgrades
  • Movers
  • News
  • Price Target
  • Tech
  • Trading Ideas

Analyst Downgrades Verizon Calling It A Bigger Loser Compared To AT&T, Cuts Price Target By 26%

By Anusuya Lahiri
August 18, 1:57 PM
The Verizon Analyst: MoffettNathanson analyst Craig Moffett downgraded Verizon Communications Inc (NYSE: VZ) 

T

Read More
2 minute read
  • Analyst Color
  • Analyst Ratings
  • Earnings
  • Movers
  • News
  • Price Target
  • Reiteration
  • Tech
  • Trading Ideas

Cisco Systems Rallies Off Q4 Earnings: 4 Analysts Break Down The Print

By Priya Nigam
August 18, 12:07 PM
Cisco Systems Inc (NASDAQ: CSCO) reported quarterly earnings of 83 cents per share, beating the consensus estimate by 1 cent per share, on revenues of $13.1 billion, ahead of the Street expectations o

CSCO

Posts pagination

Previous 1 … 648 649 650 … 689 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service